Literature DB >> 7639718

Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase.

S Namiranian1, Y Naito, V V Kakkar, M F Scully.   

Abstract

The ability of U937 monocyte-like cells and KATO III cells (a human gastric carcinoma line) to potentiate activation of plasminogen by single-chain urokinase-type plasminogen activator (scu-PA), as mediated by the cell receptor for urokinase (u-PAR), was compared. It was observed that, although the concentration of u-PAR on these cell lines differed considerably (U937 cells: 5000 receptors/cell, Kd 0.35 nM; KATO III cells: 400 receptors/cell, Kd 0.85 nM), the rate of activation of plasminogen by scu-PA in the presence of the same density of each cell line was equivalent. From data generated in the presence of increasing concentrations of scu-PA, the kcat, for plasminogen activation in the presence of each cell line was calculated and found to differ by 26-fold (0.36 s-1 on U937 cells; 9.25 s-1 on KATO III cells). However, the Km for plasminogen with respect to the rate of formation of plasmin was lower than the Kd for binding (0.2 microM compared with 0.5 microM on U937 cells; 0.34 microM compared with 1.6 microM on KATO III cells). A rapid transformation from Glu-plasminogen (native plasminogen with N-terminal Glu) to Lys-plasminogen (plasmin-degraded plasminogen with primarily N-terminal Lys-77) occurred on the surface of U937 cells (unlike KATO III cells), but this transition did not coincide with faster rates of plasminogen activation. From this evidence it is concluded that the accessibility of bound plasminogen acts to limit the rate of activation by cell-bound urokinase. The significance of this proposal is that the proteolytic potential of the cell-mediated activation of plasminogen would be controlled by the accessibility of plasminogen for activation rather than by the concentration of u-PAR (the latter may act to localize proteolysis to appropriate domains on the surface of the cell).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639718      PMCID: PMC1135727          DOI: 10.1042/bj3090977

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Establishment of cultured cell lines derived from a human gastric carcinoma.

Authors:  M Sekiguchi; K Sakakibara; G Fujii
Journal:  Jpn J Exp Med       Date:  1978-02

3.  High resolution acrylamide gel electrophoresis of histones.

Authors:  S Panyim; R Chalkley
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

4.  A proenzyme form of human urokinase.

Authors:  T C Wun; L Ossowski; E Reich
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

Review 5.  Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.

Authors:  P A Andreasen; L Sottrup-Jensen; L Kjøller; A Nykjaer; S K Moestrup; C M Petersen; J Gliemann
Journal:  FEBS Lett       Date:  1994-02-07       Impact factor: 4.124

6.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

7.  Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.

Authors:  V Ellis; K Danø
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

8.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

9.  Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

Authors:  L S Nielsen; J G Hansen; L Skriver; E L Wilson; K Kaltoft; J Zeuthen; K Danø
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

10.  Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

Authors:  J D Vassalli; J M Dayer; A Wohlwend; D Belin
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  2 in total

1.  Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.

Authors:  Mercy O Quagraine; Fulong Tan; Hironori Tamei; Ervin G Erdös; Randal A Skidgel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 2.  Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.

Authors:  Randal A Skidgel; Ervin G Erdös
Journal:  Int Immunopharmacol       Date:  2007-08-15       Impact factor: 4.932

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.